Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells. - Wikidata - awgldk - TriplyDB

Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells.

Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells.

http://www.wikidata.org/entity/Q35531194

about

The role of BST-2/Tetherin in host protection and disease manifestation Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction.Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells.The size and conservation of a coiled-coil structure in the ectodomain of human BST-2/tetherin is dispensable for inhibition of HIV-1 virion release.Roles played by capsid-dependent induction of membrane curvature and Gag-ESCRT interactions in tetherin recruitment to HIV-1 assembly sites.HIV-1 Vpu - an ion channel in search of a job.Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.Mannose Receptor 1 Restricts HIV Particle Release from Infected Macrophages.

P2860

Q26752737-E8533599-26A7-4EC3-8DCC-45B02022F774 Q28478446-FA8688D9-7BD9-4C6F-8656-203203363C6B Q35690771-14942654-2BC8-4B9D-92CF-67A7E80B296B Q36492793-A24F80EC-1581-4E2D-AACC-BBC2A87A0AF8 Q36760105-A1064595-EF42-4D33-BC7E-9F39592CAF03 Q37384691-32EFDA04-6955-4D68-AAA4-DA7DA173A49D Q37448301-1C6B8539-3B29-4CAA-991E-34A8EC88467C Q47551759-225C5CB3-5ED4-4CE7-AF34-44E310BBD6BD

P2860

Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells.

http://www.wikidata.org/entity/Q35531194

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Antibody-mediated enhancement ...... BST-2/tetherin-positive cells.

@ast

Antibody-mediated enhancement ...... BST-2/tetherin-positive cells.

@en

type

label

Antibody-mediated enhancement ...... BST-2/tetherin-positive cells.

@ast

Antibody-mediated enhancement ...... BST-2/tetherin-positive cells.

@en

prefLabel

Antibody-mediated enhancement ...... BST-2/tetherin-positive cells.

@ast

Antibody-mediated enhancement ...... BST-2/tetherin-positive cells.

@en

P1433

Q35531194-9F55B341-54B1-4673-AFDE-630EBB5CDDC0

P1476

Q35531194-36D1F907-6604-4686-94D2-66B78BC0F7D8

P2093

Q35531194-34068001-4886-4146-899B-5681EE80F38B

Q35531194-51C1F65A-D9E8-4A29-A042-F14CECC5410A

Q35531194-70AEB1ED-0124-479F-9C99-69C066646050

Q35531194-8C4BFD48-DDB6-490B-B3D7-E51B0F89F8B5

Q35531194-A9214964-D74D-41DD-B3C3-6A0773293712

P2860

Q35531194-039E9F0D-EAD0-4E74-9473-EA5D8477A5D1

Q35531194-03D37E9D-8E59-41FA-A212-41DA004686BD

Q35531194-049F0F36-78EA-44DA-9168-4BAC93FF423A

Q35531194-06B978D9-ED45-4058-B1C2-ADFFF094B707

Q35531194-0EC0A810-0A9F-45CD-AB49-684D94D8117D

Q35531194-11E0E09D-665F-4CF0-B29C-D819D62ACC41

Q35531194-1BD83F43-34AD-41EE-8739-8C5E95DA9B2B

Q35531194-1F5C44F4-2D9D-4B34-BE6F-BD3EBAD32F15

Q35531194-2426B621-C85D-425C-B07B-F2044568176A

Q35531194-28B277DB-377C-4D4C-8064-F0CFA653F2D0

P304

Q35531194-C4B45CFE-4176-45A3-85D0-0E3187E37174

P31

Q35531194-C9F0D1F2-1CCC-421A-9335-D5AC9658681F

P356

Q35531194-EB769A70-F40F-472E-9CDC-2D07A814B973

P407

Q35531194-ACD6A9B8-F2AC-4BA0-89F0-E59681236C1C

P433

Q35531194-A68A0D5E-585D-47A3-8957-B356C994D739

P478

Q35531194-9F8B8009-9879-47D4-BA5D-D226CA1B37F7

P577

Q35531194-5DAA1F09-0ACA-43CD-8040-934C3B99AA49

P698

Q35531194-C330B58A-3971-46C5-8BCC-2D6328E6D0A6

P932

Q35531194-F0447090-8169-4008-A6F3-61E4F446F15B

P356

P1433

Journal of Virology

P1476

Antibody-mediated enhancement ...... BST-2/tetherin-positive cells.

@en

P2093

Amy Andrew

http://www.w3.org/2001/XMLSchema#string

Eri Miyagi

http://www.w3.org/2001/XMLSchema#string

Klaus Strebel

http://www.w3.org/2001/XMLSchema#string

Sandra Kao

http://www.w3.org/2001/XMLSchema#string

Takeshi Yoshida

http://www.w3.org/2001/XMLSchema#string

P2860

The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2

Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain

Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth

HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms

Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin

Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism

Tetherin restricts productive HIV-1 cell-to-cell transmission

Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations

Structural insight into the mechanisms of enveloped virus tethering by tetherin

P304

11981-11994

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.05176-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21917971

http://www.w3.org/2001/XMLSchema#string

P932

3209280

http://www.w3.org/2001/XMLSchema#string